Kalyan Roy: Precision Blood Matching in Transfusion-Dependent Thalassaemia
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
“Extended Rh Phenotyping in Thalassaemia
Enhancing Transfusion Safety in Chronically Transfused Patients
Patients with thalassaemia often require lifelong regular blood transfusions. Repeated exposure to donor red cell antigens increases the risk of:
Red Cell Alloimmunization
This can lead to:
- Delayed hemolytic transfusion reactions
- Difficulty finding compatible blood
- Reduced survival of transfused RBCs
- Increased transfusion complications
What Is Extended Rh Phenotyping?
Beyond routine ABO and RhD typing, the Rh system includes clinically important antigens:
- C
- c
- E
- e
Extended Rh phenotyping identifies these antigens to provide better antigen-matched transfusion support.
Why Is It Important?
Repeated transfusions may stimulate formation of antibodies such as:
- Anti-E
- Anti-c
- Anti-C
- Anti-e
These antibodies complicate future transfusions and increase transfusion-related morbidity.
Benefits of Extended Rh Matching:
- Reduces alloimmunization risk
- Improves transfusion safety
- Decreases hemolytic reactions
- Improves red cell survival
- Simplifies future compatibility testing
- Enhances long-term patient outcomes
Example:
D Positive | C Negative | c Positive | E Negative | e Positive
A patient lacking C and E antigens may develop:
- Anti-C
- Anti-E antibodies
after exposure to antigen-positive donor blood.
Therefore, antigen-matched transfusion becomes essential.
Why Early Phenotyping Matters:
Best practice recommends performing extended Rh phenotyping:
- Before the first transfusion
or
- Early in the transfusion program
Early testing provides more accurate antigen profiling and helps prevent future complications.
Modern Transfusion Strategies:
Current best practices include:
- Leucoreduced blood components
- Extended Rh matching
- Kell antigen matching
- Antibody screening and monitoring
- Transfusion reaction surveillance
Modern transfusion medicine is evolving toward safer, precision-based patient care.
Final Thought
For thalassaemia patients, transfusion is not temporary — it is lifelong therapy.
Extended Rh phenotyping helps prevent complications before they occur and significantly improves long-term transfusion safety.
Better antigen matching means safer transfusion support.”

Other posts featuring Kalyan Roy on Hemostasis Today.
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026